Hayward, CA, United States of America

Ashraf M Wahba

This inventor holds 20 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignees: Roche Sequencing Solutions, Inc., Avails Medical, Inc., Samtec Incorporated. Active years: 2015-2025.

USPTO Granted Patents = 20 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ashraf M Wahba

Introduction: Ashraf M Wahba is a pioneering inventor based in Hayward, California, whose creative spirit and dedication to innovation have led to groundbreaking advancements in various fields.

Latest Patents: Ashraf M Wahba holds several patents in diverse areas such as technology, healthcare, and engineering, showcasing his versatility and ingenuity in developing novel solutions to complex problems.

Career Highlights: With a career spanning several decades, Ashraf M Wahba has consistently demonstrated his ability to transform ideas into tangible inventions that have a positive impact on society. His passion for innovation has driven him to push the boundaries of what is possible.

Collaborations: Throughout his career, Ashraf M Wahba has collaborated with leading experts in different industries, fostering a culture of creativity and knowledge-sharing that has been instrumental in his success as an inventor. His ability to work effectively in multidisciplinary teams has been key to the development of his groundbreaking inventions.

Conclusion: Ashraf M Wahba's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true visionary in the world of inventions. His contributions have not only transformed industries but have also inspired future generations of inventors to dream big and think outside the box.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…